Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
Background: Very preterm birth often results in the development of bronchopulmonary dysplasia (BPD) with an inverse correlation of gestational age and birthweight. This very preterm population is especially exposed to interventions, which affect the development of BPD. Objective: The goal of our rev...
Main Authors: | Tobias Muehlbacher, Dirk Bassler, Manuel B. Bryant |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/8/4/298 |
Similar Items
-
Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial
by: Yuan He, et al.
Published: (2020-09-01) -
An Update on the Prevention and Management of Bronchopulmonary Dysplasia
by: Hennelly M, et al.
Published: (2021-08-01) -
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
by: Lidys eRivera, et al.
Published: (2016-03-01) -
Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
by: Samuel J. Gentle, et al.
Published: (2020-09-01) -
Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
by: Ya-Ting Su, et al.
Published: (2021-06-01)